HCA Healthcare Inc.
03/13/2026 | Press release | Distributed by Public on 03/13/2026 14:13
Additional Proxy Soliciting Materials (Form DEFA14A)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934
|
Filed by the Registrant ☒ |
||
|
Filed by a party other than the Registrant ☐ |
||
|
Check the appropriate box: |
||
|
☐ |
Preliminary Proxy Statement |
|
| ☐ |
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
| ☐ |
Definitive Proxy Statement |
|
| ☒ |
Definitive Additional Materials |
|
| ☐ |
Soliciting Material Under Rule 240.14a-12 |
|
HCA Healthcare, Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
|
Payment of Filing Fee (Check the appropriate box): |
||
|
☒ |
No fee required. | |
|
☐ |
Fee paid previously with preliminary materials. | |
|
☐ |
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. | |
Your Vote Counts! HCA HEALTHCARE, INC. 2026 Annual Meeting Vote by April 22, 2026 11:59 PM ET. For shares held in a Plan, vote by April 20, 2026 11:59 PM ET. HCA HEALTHCARE, INC. ATTN: CORPORATE SECRETARY ONE PARK PLAZA NASHVILLE, TN 37203 V86570-P42755 You invested in HCA HEALTHCARE, INC., and it's time to vote! You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy materials for the stockholder meeting to be held on April 23, 2026. Get informed before you vote View the Notice and Proxy Statement and 2025 Annual Report online, OR you can receive a free paper or email copy of the material(s) by requesting prior to April 9, 2026. If you would like to request a copy of the material(s) for this and/or future stockholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to [email protected]. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy. For complete information and to vote, visit www.ProxyVote.com Control # Smartphone users Vote Virtually at the Meeting* Point your camera here and April 23, 2026 2:00 PM CDT vote without entering a control number Virtually at: www.virtualshareholdermeeting.com/HCA2026 *Please check the meeting materials for any special requirements for meeting attendance.
Vote at www.ProxyVote.com THIS IS NOT A VOTABLE BALLOT This is an overview of the proposals being presented at the upcoming stockholder meeting. Please follow the instructions on the reverse side to vote on these important matters. Board Voting Items Recommends 1. Election of Directors Nominees: 1a. Thomas F. Frist III For 1b. Samuel N. Hazen For 1c. John W. Chidsey, III For 1d. Nancy-Ann DeParle For 1e. William R. Frist For 1f. Hugh F. Johnston For 1g. Michael W. Michelson For 1h. Wayne J. Riley, M.D. For 1i. Andrea B. Smith For 2. To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year For ending December 31, 2026. 3. Advisory vote to approve named executive officer compensation. For 4. Stockholder proposal, if properly presented at the meeting, regarding a report on healthcare consequences. Against 5. Stockholder proposal, if properly presented at the meeting, regarding shareholders' right to act by written consent. Against NOTE: In their discretion, the proxies are authorized to vote upon any other business that may properly come before the meeting or any postponement or adjournment thereof. Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click "Delivery Settings".
HCA Healthcare Inc. published this content on March 13, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on March 13, 2026 at 20:13 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]